Lympho Bob

I have to say, I'm a little disappointed in the Follicular Lymphoma presentations at this year's American Society of Clinical Oncolo...

The ASCO Abstracts are finally available! If you've been reading the blog for a few years, you know how much I love this time of year. T...

Last week, the FDA granted accelerated approval to Breyanzi, also known as lisocabtagene maraleucel or Liso-cel, to patients with relapsed ...

I spend a  lot of time reading about cancer, as you probably know (or you can probably tell).  I get lots of stuff in my email inbox about c...

The journal Cancer Medicine  published a very interesting article lest month called " Outcomes of the transformation of follicular lymp...

That post title is a lot, but it's the subject of some very cool recent research on Follicular Lymphoma that might be a big help to us s...

It's that time of year again -- voting for the Social Health Awards is now taking place. The Social Health Awards as sponsored by Healt...